ROK vs STRO
Rockwell Automation Inc (ROK) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. Revenue was up 0.9% from 2024-09-30 to 2025-09-30. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
ROK currently screens at market cap $51.04B and trailing P/E 47.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the ROK and STRO stock pages for the full models.
Not investment advice.